BACKGROUND: Association between genetic variants located on human chromosome 8q24.21 with an increased risk for prostatic carcinoma has been well established. POU5F1P1, a processed pseudogene homologous to the pluripotency factor OCT4, is the only sequence with coding capacity in this region. The objective of this study was to investigate the POU5F1P1 expression in prostatic carcinoma and carcinoma surrounding prostatic tissue. METHODS: RT-PCR and real-time PCR was used to measure the expression of POU5F1P1 relative to the expression of HPRT1 in cell lines, prostatic carcinoma and carcinoma surrounding prostatic tissue. The structure of the POU5F1P1 mRNA and the promoter sequence were elucidated by 5'-RACE experiments. The POU5F1P1 protein was shown with immunohistochemistry on prostate tissue. RESULTS: POU5F1P1 was found to be the only member of the POU5F1 family to be expressed in prostate with over-expression in prostatic carcinoma compared to surrounding prostatic tissue probably because of an increased density of expressing cells. The POU5F1P1 expression is driven by a variety of promoter structures scattered over a genomic region of 860 kB. CONCLUSIONS: The over-expression of POU5F1P1 in prostatic carcinoma in addition to its genomic location and the putative function of its gene product render POU5F1P1 a good candidate to harbour functional genetic variants which modulate prostatic cancer susceptibility.
BACKGROUND: Association between genetic variants located on human chromosome 8q24.21 with an increased risk for prostatic carcinoma has been well established. POU5F1P1, a processed pseudogene homologous to the pluripotency factor OCT4, is the only sequence with coding capacity in this region. The objective of this study was to investigate the POU5F1P1 expression in prostatic carcinoma and carcinoma surrounding prostatic tissue. METHODS: RT-PCR and real-time PCR was used to measure the expression of POU5F1P1 relative to the expression of HPRT1 in cell lines, prostatic carcinoma and carcinoma surrounding prostatic tissue. The structure of the POU5F1P1 mRNA and the promoter sequence were elucidated by 5'-RACE experiments. The POU5F1P1 protein was shown with immunohistochemistry on prostate tissue. RESULTS:POU5F1P1 was found to be the only member of the POU5F1 family to be expressed in prostate with over-expression in prostatic carcinoma compared to surrounding prostatic tissue probably because of an increased density of expressing cells. The POU5F1P1 expression is driven by a variety of promoter structures scattered over a genomic region of 860 kB. CONCLUSIONS: The over-expression of POU5F1P1 in prostatic carcinoma in addition to its genomic location and the putative function of its gene product render POU5F1P1 a good candidate to harbour functional genetic variants which modulate prostatic cancer susceptibility.
Authors: Kathryn Hughes Barry; Lee E Moore; Joshua Sampson; Liying Yan; Ann Meyer; Andrew J Oler; Charles C Chung; Zhaoming Wang; Meredith Yeager; Laufey Amundadottir; Sonja I Berndt Journal: Cancer Prev Res (Phila) Date: 2014-10-14
Authors: Julia Ciampa; Meredith Yeager; Laufey Amundadottir; Kevin Jacobs; Peter Kraft; Charles Chung; Sholom Wacholder; Kai Yu; William Wheeler; Michael J Thun; W Ryan Divers; Susan Gapstur; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; David Hunter; Robert Hoover; Gilles Thomas; Stephen Chanock; Nilanjan Chatterjee Journal: Cancer Res Date: 2011-03-03 Impact factor: 12.701
Authors: Joan P Breyer; Daniel C Dorset; Travis A Clark; Kevin M Bradley; Tiina A Wahlfors; Kate M McReynolds; William H Maynard; Sam S Chang; Michael S Cookson; Joseph A Smith; Johanna Schleutker; William D Dupont; Jeffrey R Smith Journal: Am J Hum Genet Date: 2014-02-27 Impact factor: 11.025
Authors: H Hayashi; T Arao; Y Togashi; H Kato; Y Fujita; M A De Velasco; H Kimura; K Matsumoto; K Tanaka; I Okamoto; A Ito; Y Yamada; K Nakagawa; K Nishio Journal: Oncogene Date: 2013-12-23 Impact factor: 9.867
Authors: Marina França de Resende; Ludmilla Thomé Domingos Chinen; Samantha Vieira; Juliano Jampietro; Francisco Paulo da Fonseca; José Vassallo; Luciene Cristina Campos; Gustavo Cardoso Guimarães; Fernando Augusto Soares; Rafael Malagoli Rocha Journal: Tumour Biol Date: 2013-05-01
Authors: Shanker Kalyana-Sundaram; Chandan Kumar-Sinha; Sunita Shankar; Dan R Robinson; Yi-Mi Wu; Xuhong Cao; Irfan A Asangani; Vishal Kothari; John R Prensner; Robert J Lonigro; Matthew K Iyer; Terrence Barrette; Achiraman Shanmugam; Saravana M Dhanasekaran; Nallasivam Palanisamy; Arul M Chinnaiyan Journal: Cell Date: 2012-06-22 Impact factor: 41.582
Authors: Jiajun Shi; Yanfeng Zhang; Wei Zheng; Kyriaki Michailidou; Maya Ghoussaini; Manjeet K Bolla; Qin Wang; Joe Dennis; Michael Lush; Roger L Milne; Xiao-Ou Shu; Jonathan Beesley; Siddhartha Kar; Irene L Andrulis; Hoda Anton-Culver; Volker Arndt; Matthias W Beckmann; Zhiguo Zhao; Xingyi Guo; Javier Benitez; Alicia Beeghly-Fadiel; William Blot; Natalia V Bogdanova; Stig E Bojesen; Hiltrud Brauch; Hermann Brenner; Louise Brinton; Annegien Broeks; Thomas Brüning; Barbara Burwinkel; Hui Cai; Sander Canisius; Jenny Chang-Claude; Ji-Yeob Choi; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Hatef Darabi; Peter Devilee; Arnaud Droit; Thilo Dork; Peter A Fasching; Olivia Fletcher; Henrik Flyger; Florentia Fostira; Valerie Gaborieau; Montserrat García-Closas; Graham G Giles; Pascal Guenel; Christopher A Haiman; Ute Hamann; Mikael Hartman; Hui Miao; Antoinette Hollestelle; John L Hopper; Chia-Ni Hsiung; Hidemi Ito; Anna Jakubowska; Nichola Johnson; Diana Torres; Maria Kabisch; Daehee Kang; Sofia Khan; Julia A Knight; Veli-Matti Kosma; Diether Lambrechts; Jingmei Li; Annika Lindblom; Artitaya Lophatananon; Jan Lubinski; Arto Mannermaa; Siranoush Manoukian; Loic Le Marchand; Sara Margolin; Frederik Marme; Keitaro Matsuo; Catriona McLean; Alfons Meindl; Kenneth Muir; Susan L Neuhausen; Heli Nevanlinna; Silje Nord; Anne-Lise Børresen-Dale; Janet E Olson; Nick Orr; Ans M W van den Ouweland; Paolo Peterlongo; Thomas Choudary Putti; Anja Rudolph; Suleeporn Sangrajrang; Elinor J Sawyer; Marjanka K Schmidt; Rita K Schmutzler; Chen-Yang Shen; Ming-Feng Hou; Matha J Shrubsole; Melissa C Southey; Anthony Swerdlow; Soo Hwang Teo; Bernard Thienpont; Amanda E Toland; Robert A E M Tollenaar; Ian Tomlinson; Therese Truong; Chiu-Chen Tseng; Wanqing Wen; Robert Winqvist; Anna H Wu; Cheng Har Yip; Pilar M Zamora; Ying Zheng; Giuseppe Floris; Ching-Yu Cheng; Maartje J Hooning; John W M Martens; Caroline Seynaeve; Vessela N Kristensen; Per Hall; Paul D P Pharoah; Jacques Simard; Georgia Chenevix-Trench; Alison M Dunning; Antonis C Antoniou; Douglas F Easton; Qiuyin Cai; Jirong Long Journal: Int J Cancer Date: 2016-06-17 Impact factor: 7.396